(354e) The Art of the Possible When Digitising Your Pharmaceutical Operations | AIChE

(354e) The Art of the Possible When Digitising Your Pharmaceutical Operations

Authors 

Jones, P. - Presenter, Director Pharma & Life Sciences, PwC Consulting
The Pharma and Life Sciences sector is in the midst of rapid, fundamental change. Manufacturers are embarking on digital transformation projects across the globe but there are few that have unlocked their full potential. From Industry 4.0, Digitisation to the opportunities that Continuous Manufacturing can bring, a transformation in the operations agenda is evident. For many manufacturers, a profound transformation is required, integrating business understanding and human insights with technology innovation. We will take a look at the manufacturers who have embarked on digital transformation and are leading the way, discuss what's holding some companies back, and discuss what can be done now to stay ahead of the global competition. With a lens on emerging Industry 4.0 technologies, how Continuous Manufacturing can be an enabler of the Digitisation agenda, we will consider some of the immediate challenges and the future opportunities that will deliver 'real' business benefit and ultimately patient value.